High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$1.3M
$1,286,711
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| ORKA |
Oruka Therapeutics, Inc.
|
President
Sell to Cover
|
2026-03-16 | $16,313 | S | Form 4 |
|
ORKA
S
Oruka Therapeutics, Inc.
Goncalves Joana
• Officer • Chief Medical Officer
Sell to Cover
2026-03-16
$312,560x4
|
||||||
| ORKA |
Oruka Therapeutics, Inc.
|
Officer • Chief Medical Officer
Sell to Cover
|
2026-03-16 | $312,560x4 | S | Form 4 |
| ORKA |
Oruka Therapeutics, Inc.
|
CEO
Sell to Cover
|
2026-03-16 | $71,408 | S | Form 4 |
|
ORKA
S
Oruka Therapeutics, Inc.
Quinlan Paul T
• Officer • General Counsel
Sell to Cover
2026-03-16
$30,273
|
||||||
| ORKA |
Oruka Therapeutics, Inc.
|
Officer • General Counsel
Sell to Cover
|
2026-03-16 | $30,273 | S | Form 4 |
| ORKA |
Oruka Therapeutics, Inc.
|
COO
Sell to Cover
|
2026-03-16 | $24,780 | S | Form 4 |
| ORKA |
Oruka Therapeutics, Inc.
|
COO
10b5-1 Sell
|
2026-03-02 | $167,822x2 | S | Form 4 |
|
ORKA
S
Oruka Therapeutics, Inc.
Goncalves Joana
• Officer • Chief Medical Officer
10b5-1 Sell
2026-02-17
$226,559x2
|
||||||
| ORKA |
Oruka Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2026-02-17 | $226,559x2 | S | Form 4 |
|
ORKA
S
Oruka Therapeutics, Inc.
Goncalves Joana
• Officer • Chief Medical Officer
10b5-1 SellΔOwn -51.4%
2026-01-15
$222,704x2
|
||||||
| ORKA |
Oruka Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 SellΔOwn -51.4%
|
2026-01-15 | $222,704x2 | S | Form 4 |
|
ORKA
S
Oruka Therapeutics, Inc.
Goncalves Joana
• Officer • Chief Medical Officer
10b5-1 Sell
2025-12-19
$214,293x4
|
||||||
| ORKA |
Oruka Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2025-12-19 | $214,293x4 | S | Form 4 |